Advances in the application of quantum dots in tumor markers investigation

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 3, 2008, Pages 179-184

  Chen, Chuang ^a   Chen, Liangdong ^a   Zhang, Zhiling ^a   Li, Yan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Bio probes; Biomedical application; Cancer; Quantum dots; Tumor markers

Indexed keywords

EID: 42549121972     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-007-0188-z     Document Type: Article

References (50)

1. China Healthcare Statistics Report, 2006. Ministry of Public Health of People's Republic of China. http://www.moh.gov.cn/newshtml/18903.htm.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin, 2005, 55: 10-30.
3. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer, 2005, 5: 845-856.
4. Sun Z, Fu X, Zhang L, et al. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection. Anticancer Res, 2004, 24: 1159-1165.
5. Chen C, Yang GL, Li Y, et al. The value of tumor markers in the diagnosis and monitoring of gastric cancer and the strategies for further improvement: Analysis of 100 cases. J New Med (Chinese), 2007, 17: 15-19.
6. Chen C, Chen LQ, Yang GL, et al. Value of tumor markers in diagnosing and monitoring colorectal cancer and the strategies for further improvement: Analysis of 130 cases. Cancer (Chinese), 2007, 26:1221-1226.
7. Hammond ME, Taube SE. Issues and barriers to development of clinically useful tumor markers: A development pathway proposal. Semin Oncol, 2002, 29: 213-221.
8. Leary SP, Liu CY, Apuzzo ML. Toward the emergence of nanoneurosurgery: part II - nanomedicine: Diagnostics and imaging at the nanoscale level. Neurosurgery, 2006, 58: 805-823.
9. Pinaud F, Michalet X, Bentolila LA, et al. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials, 2006, 27: 1679-1687.
10. Smith AM, Dave S, Nie S, et al. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn, 2006, 6: 231-244.
11. Chen LD, Li Y, Pang DW. Quantum dots and their applications in cancer research. Chin J Cancer (Chinese), 2006, 25: 651-656.
12. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol, 2001, 19: 316-317.
13. Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 2004, 22: 969-976.
14. Gao X, Chung LW, Nie S. Quantum dots for in vivo molecular and cellular imaging. Methods Mol Biol, 2007, 374: 135-146.
15. Yu WW, Chang E, Drezek R, et al. Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun, 2006, 348:781-786.
16. Weng J, Ren J. Luminescent quantum dots: A very attractive and promising tool in biomedicine. Curr Med Chem, 2006, 13: 897-909.
17. Pradhan N, Battaglia DM, Liu Y, et al. Efficient, stable, small, and water-soluble doped ZnSe nanocrystal emitters as non-cadmium biomedical labels. Nano Lett, 2007, 7: 312-317.
18. Bentzen EL, Tomlinson ID, Mason J, et al. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug Chem, 2005, 16: 1488-1494.
19. Yu WW, Chang E, Falkner JC, et al. Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers. J Am Chem Soc, 2007, 129: 2871-2879.
20. Bruchez M Jr, Moronne M, Gin P, et al. Semiconductor nanocrystals as fluorescent biological labels. Science, 1998, 281: 2013-2016.
21. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science, 1998, 281: 2016-2018.
22. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science, 2005, 307: 538-544.
23. Gao X, Yang L, Petros JA, et al. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol, 2005, 16: 63-72.
24. Coussens L, Yang-Feng TL, Liao YC, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 1985, 230: 1132-1139.
25. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 1987, 235: 177-182.
26. Lipton A, Ali SM, Leitzed K, et al. Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol, 2002, 20: 1467-1472.
27. Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol, 2003, 21: 41-46.
28. Li-Shishido S, Watanabe TM, Tada H, et al. Reduction in nonfluorescence state of quantum dots on an immunofluorescence staining. Biochem Biophys Res Commun, 2006, 351: 7-13.
29. Zheng F, Shi XW, Yang GF, et al. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study. Life Sci, 2007, 80: 388-396.
30. Tana WB, Jiang S, Zhang Y. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials, 2007, 28: 1565-1571.
31. Tada H, Higuchi H, Wanatabe TM, et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res, 2007, 67: 1138-1144.
32. Espana F, Martinez M, Royo M, et al. Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia. Eur Urol, 1997, 32: 268-272.
33. Taneja SS, Hsu EI, Cheli CD, et al. Complexed prostate-specific antigen as a staging tool: Results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis. Urology, 2002, 60: 10-17.
34. Azzazy HM, Mansour MM, Kazmierczak SC. Nanodiagnostics: A new frontier for clinical laboratory medicine. Clin Chem, 2006, 52: 1238-1246.
35. Kerman K, Endo T, Tsukamoto M, et al. Quantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopy. Talanta, 2007, 71: 1494-1499.
36. Follen M, Schottenfeld D. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials. Cancer, 2001, 91: 1758-1776.
37. Nida DL, Rahman MS, Carlson KD, et al. Fluorescent nanocrystals for use in early cervical cancer detection. Gynecol Oncol, 2005, 99: S89-S94.
38. Rahman M, Abd-El-Barr M, Mack V, et al. Optical imaging of cervical pre-cancers with strucrured illumination: An integrated approach. Gynecol Oncol, 2005, 99: S112-S115.
39. Lidke DS, Nagy P, Heintzmann R, et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol, 2004, 22: 198-203.
40. Chen LD, Liu J, Li Y, et al. Immuno-fluorescence imaging of hepatocellular carcinoma cells with quantum dots. Chin J Exp Sur (Chinese), 2006, 23: 1085-1087.
41. Chen LD, Liu J, Yu XF, et al. In vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes. Chin J Pathol (Chinese), 2007, 36: 394-399.
42. Yu XF, Chen LD, Deng YL, et al. Fluorescence analysis with quantum dot probes for hepatoma under nne-and two-photon excitation. J Fluoresc, 2007, 17: 243-247.
43. Bast RC Jr, Krug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med, 1983, 309: 883-887.
44. Wang HZ, Wang HY, Liang RQ, et al. Detection of tumor marker CA125 in ovarian carcinoma using quantum dots. Acta Biochim Biophys Sin (Shanghai), 2004, 36: 681-686.
45. Hardman R. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ Health Perspect, 2006, 114: 165-172.
46. Dubertret B, Skourides P, Norris DJ, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 2002, 298: 1759-1762.
47. Chang E, Thekkek N, Yu WW, et al. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small (Weinheim an der Bergstrasse, Germany), 2006, 2: 1412-1417.
48. Kim SW, Kim S, Tracy JB, et al. Phosphine oxide polymer for watersoluble nanoparticles. J Am Chem Soc, 2005, 127: 4556-4557.
49. Warshaw DM, Kennedy GG, Work SS, et al. Differential labeling of myosin V heads with quantum dots allows direct visualization of hand-over-hand processivity. Biophys J, 2005, 88: L30-L32.
50. Hall M, Kazakova I, Yao YM. High sensitivity immunoassays using particulate fluorescent labels. Anal Biochem, 1999, 272: 165-170.